Boston Partners’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-219,427
Closed -$6.18M 760
2016
Q1
$6.18M Hold
219,427
0.01% 436
2015
Q4
$13.4M Buy
+219,427
New +$13.3M 0.02% 353
2014
Q2
Sell
-129,441
Closed -$8.89M 754
2014
Q1
$8.89M Sell
129,441
-507,102
-80% -$35.9M 0.02% 415
2013
Q4
$42.9M Sell
636,543
-275,134
-30% -$15.7M 0.09% 200
2013
Q3
$41.4M Sell
911,677
-654,408
-42% -$26.3M 0.1% 186
2013
Q2
$57.6M Buy
+1,566,085
New +$56.3M 0.16% 139

Other funds holding ENDP

Boston Partners's ENDP Position: Q2 2016 in Review

Boston Partners sold out of Endo International plc (ENDP) in Q2 2016, closing a stake of 219,427 shares — an estimated $6.18M sold.

Boston Partners first reported a position in ENDP in Q2 2013 and held it in 6 quarters. The position peaked at $57.6M in Q2 2013. 301 funds tracked by Wall St. Rank hold ENDP as of Q2 2016.

  • Boston Partners reported no remaining Endo International plc position as of Q2 2016 after selling out during the quarter.
  • Boston Partners sold 219,427 Endo International plc shares in Q2 2016, an estimated $6.18M.
  • Boston Partners first reported a position in Endo International plc in Q2 2013 and held it in 6 quarters.
  • Boston Partners's Endo International plc position peaked at $57.6M in Q2 2013.
  • 301 funds tracked by Wall St. Rank held Endo International plc as of Q2 2016.

Based on Boston Partners's 13F filing for Q2 2016, filed 5 Aug 2016.